Abstract
Neurofibroma type 1 (NFI) is an autosomal dominant genetic disease associated with cancer and cognitive dysfunction. The 50% de novo mutation rate and numerous mutation types of the NF1 gene pose challenges to preimplantation genetic testing (PGT) for NFI. In 2020, a couple was subjected to next-generation sequencing (NGS)-based PGT at our center. Both husband and wife carried de novo NF1 mutations. Biopsied trophectoderm samples underwent whole-genome amplification using multiple displacement amplification. NGS was conducted to detect NF1 mutations as well as 105 closely linked single-nucleotide polymorphisms (SNPs) flanking NF1. Since no affected family member was available, the affected embryos identified by NF1-targeted sequencing were assigned as probands, based on which a haplotype analysis was constructed with informative SNP sites. Sanger sequencing was administrated for verification. Aneuploidy screening through NGS was performed in the same PGT cycle. Finally, among the nine biopsied blastocysts, two unaffected and euploid blastocysts were obtained in the couple, and one of the blastocysts was transferred in a frozen–thawed embryo transfer (FET) cycle. The outcome of FET is under observation. This study is the first to apply NGS-based PGT for NFI. In cases of sporadic NFI cases without affected family members, NGS-SNP can perform haploid analysis in an accurate manner by assigning the affected embryos as probands.
Similar content being viewed by others
References
Evans, D.G., Howard, E., Giblin, C., Clancy, T., Spencer, H., Huson, S.M., Lalloo, F.: Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am. J. Med. Genet. Part A 152a, 327–332 (2010)
Gutmann, D.H., Ferner, R.E., Listernick, R.H., Korf, B.R., Wolters, P.L., Johnson, K.J.: Neurofibromatosis type 1. Nat Rev. Dis. Primers 3, 17004 (2017)
Rad, E., Tee, A.R.: Neurofibromatosis type 1: fundamental insights into cell signalling and cancer. Semin. Cell Dev. Biol. 52, 39–46 (2016)
Uusitalo, E., Rantanen, M., Kallionpää, R.A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V.M., Pukkala, E., Pitkäniemi, J., Peltonen, S., Peltonen, J.: Distinctive cancer associations in patients with neurofibromatosis type 1. J. Clin. Oncol. 34, 1978–1986 (2016)
Evans, D.G., O’hara, C., Wilding, A., Ingham, S.L., Howard, E., Dawson, J., Moran, A., Scott-Kitching, V., Holt, F., Huson, S.M.: Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989. Eur. J. Hum. Genet. 19, 1187–1191 (2011)
Torres Nupan, M.M., Van Meerbeke, A.V., Lopez Cabra, C.A., Herrera Gomez, P.M.: Cognitive and behavioral disorders in children with neurofibromatosis type 1. Front. Pediatr. 5, 227 (2017)
Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D.G., Huson, S.M.: Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 132, e1642–e1648 (2013)
Verlinsky, Y., Rechitsky, S., Verlinsky, O., Xu, K., Schattman, G., Masciangelo, C., Ginberg, N., Strom, C., Rosenwaks, Z., Kuliev, A.: Preimplantation diagnosis for p53 tumour suppressor gene mutations. Reprod. Biomed. Online 2, 102–105 (2001)
Lipton, J.H., Zargar, M., Warner, E., Greenblatt, E.E., Lee, E., Chan, K.K., Wong, W.W.: Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations. Hum. Reprod. 35, 434–445 (2020)
Merker, V.L., Murphy, T.P., Hughes, J.B., Muzikansky, A., Hughes, M.R., Souter, I., Plotkin, S.R.: Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1. Fertil. Steril. 103, 761–8.e1 (2015)
Spits, C., De Rycke, M., Van Ranst, N., Verpoest, W., Lissens, W., Van Steirteghem, A., Liebaers, I., Sermon, K.: Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat. Diagn. 27, 447–456 (2007)
Spits, C., De Rycke, M., Van Ranst, N., Joris, H., Verpoest, W., Lissens, W., Devroey, P., Van Steirteghem, A., Liebaers, I., Sermon, K.: Preimplantation genetic diagnosis for neurofibromatosis type 1. Mol. Hum. Reprod. 11, 381–387 (2005)
Wang, J., Lu, B.M., Li, R., Guo, J., Xu, Y., Pan, J.F., Zeng, Y.H., Zhou, C.Q., Xu, Y.W.: Karyomapping in preimplantation genetic testing for beta-thalassemia combined with HLA matching: a systematic summary. J. Assist. Reprod. Gen. 36, 2515–2523 (2019)
Pennisi, E.: A closer look at SNPs suggests difficulties. Science (New York, N.Y.) 281(5384), 1787–1789 (1998)
Hinrichs, A.L., Bertelsen, S., Bierut, L.J., Dunn, G., Jin, C.H., Kauwe, J.S., Suarez, B.K.: Multipoint identity-by-descent computations for single-point polymorphism and microsatellite maps. BMC Genet. 6, S34 (2005)
Shen, X.T., Chen, D.J., Xu, Y., Fu, Y., Zhou, C.Q.: Preimplantation genetic testing of achondroplasia by two haplotyping systems: short tandem repeats and single nucleotide polymorphism. BioChip J. 13, 165–173 (2019)
Rechitsky, S., Kuliev, A., Ramon, G.S., Tur-Kaspa, I., Wang, Y., Wang, W., Wu, X., Wang, L., Leigh, D., Cram, D.S.: Single-molecule sequencing: a new approach for preimplantation testing and noninvasive prenatal diagnosis confirmation of fetal genotype. J. Mol. Diagn. 22, 220–227 (2020)
Treff, N.R., Fedick, A., Tao, X., Devkota, B., Taylor, D., Scott, R.T., Jr.: Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil. Steril. 99, 1377-1384.e6 (2013)
Chen, D., Shen, X., Wu, C., Xu, Y., Ding, C., Zhang, G., Xu, Y., Zhou, C.: Eleven healthy live births: a result of simultaneous preimplantation genetic testing of alpha- and beta-double thalassemia and aneuploidy screening. J. Assist. Reprod. Gen. 37, 549–557 (2020)
Ji, X., Zhang, Z., Shi, J., He, B.: Clinical application of NGS-based SNP haplotyping for the preimplantation genetic diagnosis of primary open angle glaucoma. Syst. Biol. Reprod. Med. 65, 258–263 (2019)
Ren, Y., Zhi, X., Zhu, X., Huang, J., Lian, Y., Li, R., Jin, H., Zhang, Y., Zhang, W., Nie, Y., Wei, Y.: Clinical applications of MARSALA for preimplantation genetic diagnosis of spinal muscular atrophy. J. Genet. Genom. 43, 541–547 (2016)
Chen, L., Diao, Z., Xu, Z., Zhou, J., Yan, G., Sun, H.: The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfecta. Syst. Biol. Reprod. Med. 65, 75–80 (2019)
Tucker, T., Friedman, J.M.: Pathogenesis of hereditary tumors: beyond the “two-hit” hypothesis. Clin. Genet. 62, 345–357 (2002)
Kehrer-Sawatzki, H., Mautner, V.F., Cooper, D.N.: Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum. Genet. 136, 349–376 (2017)
Lee, M.J., Su, Y.N., You, H.L., Chiou, S.C., Lin, L.C., Yang, C.C., Lee, W.C., Hwu, W.L., Hsieh, F.J., Stephenson, D.A., Yu, C.L.: Identification of forty-five novel and twenty-three known NF1 mutations in Chinese patients with neurofibromatosis type 1. Hum. Mutat. 27, 832 (2006)
Koczkowska, M., Chen, Y., Callens, T., Gomes, A., Sharp, A., Johnson, S., Hsiao, M.C., Chen, Z., Balasubramanian, M., Barnett, C.P., Becker, T.A.: Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844–848. Am. J. Hum. Genet. 102, 69–87 (2018)
Handyside, A.H., Harton, G.L., Mariani, B., Thornhill, A.R., Affara, N., Shaw, M.A., Griffin, D.K.: Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. Am. J. Med. Genet. 47, 651–658 (2010)
Chen, S.C., Xu, X.L., Zhang, J.Y., Ding, G.L., Jin, L., Liu, B., Sun, D.M., Mei, C.L., Yang, X.N., Huang, H.F., Xu, C.M.: Identification of PKD2 mutations in human preimplantation embryos in vitro using a combination of targeted next-generation sequencing and targeted haplotyping. Sci. Rep. 6, 25488 (2016)
Wang, Y., Qin, M., Yan, Z., Guan, S., Kuo, Y., Kong, S., Nie, Y., Zhu, X., Zhi, X., Qiao, J., Yan, L.: A strategy using SNP linkage analysis for monogenic diseases PGD combined with HLA typing. Clin. Genet. 98, 138–146 (2020)
Chen, Y.L., Hung, C.C., Lin, S.Y., Fang, M.Y., Tsai, Y.Y., Chang, L.J., Lee, C.N., Su, Y.N., Chen, S.U., Yang, Y.S.: Successful application of the strategy of blastocyst biopsy, vitrification, whole genome amplification, and thawed embryo transfer for preimplantation genetic diagnosis of neurofibromatosis type 1. Taiwan J. Obstet. Gynecol. 50, 74–78 (2011)
Verlinsky, Y., Rechitsky, S., Verlinsky, O., Chistokhina, A., Sharapova, T., Masciangelo, C., Levy, M., Kaplan, B., Lederer, K., Kuliev, A.: Preimplantation diagnosis for neurofibromatosis. Reprod. Biomed. Online 4, 218–222 (2002)
Altarescu, G., Brooks, B., Kaplan, Y., Eldar-Geva, T., Margalioth, E.J., Levy-Lahad, E., Renbaum, P.: Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum. Reprod. 21, 2047–2051 (2006)
Liu, L., Li, Y., Li, S., Hu, N., He, Y., Pong, R., Lin, D., Lu, L., Law, M.: Comparison of next-generation sequencing systems. J. Biomed. Biotechnol. 2012, 251364 (2012)
Chan, E.Y.: Advances in sequencing technology. Mutat. Res. 573, 13–40 (2005)
van Dijk, E.L., Auger, H., Jaszczyszyn, Y., Thermes, C.T.: years of next-generation sequencing technology. Trends Genet. 30, 418–426 (2014)
Slatko, B.E., Gardner, A.F., Ausubel, F.M.: Overview of next-generation sequencing technologies. Curr. Protoc. Mol. Biol. 122, e59 (2018)
Bentley, D.R., Balasubramanian, S., Swerdlow, H.P., Smith, G.P., Milton, J., Brown, C.G., Hall, K.P., Evers, D.J., Barnes, C.L., Bignell, H.R., Boutell, J.M.: Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456, 53–59 (2008)
Hou, W., Xu, Y., Li, R., Song, J., Wang, J., Zeng, Y., Pan, J., Zhou, C., Xu, Y.: Role of aneuploidy screening in preimplantation genetic testing for monogenic diseases in young women. Fertil. Steril. 111, 928–935 (2019)
Chen, L., Diao, Z., Xu, Z., Zhou, J., Yan, G., Sun, H.: The clinical application of NGS-based SNP haplotyping for PGD of Hb H disease. Syst. Biol. Reprod. Med. 63, 212–217 (2017)
Zhang, C., Zhang, C., Chen, S., Yin, X., Pan, X., Lin, G., Tan, Y., Tan, K., Xu, Z., Hu, P., Li, X.: A single cell level based method for copy number variation analysis by low coverage massively parallel sequencing. PLoS ONE 8, e54236 (2013)
Yin, X., Tan, K., Vajta, G., Jiang, H., Tan, Y., Zhang, C., Chen, F., Chen, S., Zhang, C., Pan, X., Gong, C.: Massively parallel sequencing for chromosomal abnormality testing in trophectoderm cells of human blastocysts. Biol. Reprod. 88, 69 (2018)
Rechitsky, S., Verlinsky, O., Chistokhina, A., Sharapova, T., Ozen, S., Masciangelo, C., Kuliev, A., Verlinsky, Y.: Preimplantation genetic diagnosis for cancer predisposition. Reprod. Biomed. Online 5, 148–155 (2002)
Scott, K.L., Hong, K.H., Scott, R.T., Jr.: Selecting the optimal time to perform biopsy for preimplantation genetic testing. Fertil. Steril. 100, 608–614 (2013)
Griffin, D.K., Ogur, C.: Chromosomal analysis in IVF: just how useful is it? Reproduction (Cambridge, England) 156, F29-f50 (2018)
Gardner, D.K., Lane, M., Stevens, J., Schlenker, T., Schoolcraft, W.B.: Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil. Steril. 73, 1155–8 (2000)
Acknowledgements
This study was supported by the National Key R&D Program of China (2016YFC1000205), the National Natural Science Foundation of China (32000589), the Guangdong Basic and Applied Basic Research Foundation (2114050000636), the Guangdong Provincial Key Laboratory of Reproductive Medicine (2012A061400003) and the Guangzhou Science and Technology Project: Development and Application of The Reagents for Preimplantation Diagnosis and Screening by Next-Generation Sequencing (201704020217). The authors thank Dr. Zhang Qian of Peking Jabrehoo Med Tech for providing data analysis for this study.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
No conflicts of interest exist.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, D., Shen, X., Xu, Y. et al. Next-Generation Sequencing-Based Preimplantation Genetic Testing for De Novo NF1 Mutations. BioChip J 15, 69–76 (2021). https://doi.org/10.1007/s13206-021-00006-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-021-00006-3